Suchergebnisse - "Carpagnano, Giovanna Elisiana"

PubPharm (5)

1

Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity : A Real-Life Perspective

enthalten in: Biomedicines | 2024

von Caminati, M. | Maule, M. | Benoni, R. | +23

2

Effectiveness of benralizumab in severe eosinophilic asthma : Distinct sub-phenotypes of response identified by cluster analysis

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2022

von Di Bona, D. | Crimi, C. | D'Uggento, A. | +18

CommentIn: Clin Exp Allergy. 2022 Feb;52(2):359-360. - PMID 34792257

3

Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management

enthalten in: Multidisciplinary respiratory medicine | 2022

von Carpagnano, G. | Scioscia, G. | Buonamico, E. | +6

4

Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

enthalten in: Expert review of respiratory medicine | 2021

von Malipiero, G. | Paoletti, G. | Blasi, F. | +10

5

Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients : Our Real-Life Experience

enthalten in: Frontiers in pharmacology | 2021

von Scioscia, G. | Carpagnano, G. | Quarato, C. | +6

1
[1]